Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-FR Version v5-FR
Language French French
Date Updated 2020-04-07 2020-01-14
Drug Identification Number 02377608 02377608
Brand name APO-MONTELUKAST APO-MONTELUKAST
Common or Proper name MONTELUKAST MONTELUKAST
Company Name APOTEX INC APOTEX INC
Ingredients MONTELUKAST MONTELUKAST
Strength(s) 4MG 4MG
Dosage form(s) TABLET (CHEWABLE) TABLET (CHEWABLE)
Route of administration ORAL ORAL
Packaging size 30 BLS 30 BLS
ATC code R03DC R03DC
ATC description OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-11-18 2019-11-18
Estimated end date Unknown Unknown
Actual end date 2020-04-03
Shortage status Resolved Actual shortage
Company comments
Health Canada comments